Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Tirzepatide is a novel dual agonist medication that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
The practical implication: if you are choosing between semaglutide and tirzepatide based solely on published trial outcomes (15% vs 20% weight loss), you are optimizing the wrong variable
This whole-person approach supports lasting results rather than temporary fixes
The same principle applies here: pick a spot within the abdominal zone where you can comfortably pinch at least 1 to 2 inches of soft tissue
GLP-1 medications like Ozempic, Wegovy, and Mounjaro have completely changed the weight-loss conversation, and honestly, a lot of the advice floating around online right now is either written by people with zero nutrition training or copy-pasted from a pharma FAQ page
This is dose-related and usually fades by week 4-6
